venBio Partners LLC - Stock Holdings in 13F Filings (SEC)

Updated on March 15, 2026.

Based on 13F Filings filed with the SEC on February 17, 2026, for the 2025 Q4 period, venBio Partners LLC held in its portfolio 6 assets valued at $216,272,926 (i.e. $216.27M).

The most valuable assets in the portfolio included: PHARVARIS N V ($128.74M), ALUMIS INC ($45.09M), and HARMONY BIOSCIENCES HLDGS IN ($18.31M).

The chart below shows the top 6 valuable assets, and the table below shows the top 6 valuable assets.

You can see similar for other investment managers.

Related Topics: SEC Topic List.

Data Source: SEC.

Top Valuable Stocks in venBio Partners LLC Portfolio

PHARVARIS N V

ALUMIS INC

HARMONY BIOSCIENCES HLDGS IN

ALX ONCOLOGY HLDGS INC

LYELL IMMUNOPHARMA INC

ARTIVA BIOTHERAPEUTICS INC

venBio Partners LLC - Stock Holdings in 13F Filings (SEC)

Items per page:

0 of 0

Name of Issuer	No. of Shares	Value ($)	Class
PHARVARIS N V	4639304	128740686	COM
ALUMIS INC	4619803	45089277	COM
HARMONY BIOSCIENCES HLDGS IN	489194	18305639	COM
ALX ONCOLOGY HLDGS INC	9699925	10960915	COM
LYELL IMMUNOPHARMA INC	337697	10394314	COM NEW
ARTIVA BIOTHERAPEUTICS INC	648507	2782095	COM